CD34 and myelodysplastic syndrome: To identify alternative splice variants, RNA splicing analysis is usually performed using bone marrow (BM) CD34+ hematopoietic stem/progenitor cells (HSPCs) or mononuclear cells from patients with MDS (16, 18, 19, 28, 29).